日付

担当者

まとめ

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

福田

児玉

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.

児玉

児玉

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

金澤

石井

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study 

大越

Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis.

児玉

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

井部

Novel therapies for malignant pleural mesothelioma

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and

Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

J. Immunotherapy of Cancer 2018

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

 JCO 2018

Cancer immunotherapy efficacy and patients’ sex: a systematic review and meta-analysis

Lancet 2018

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

NEJM 2018

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients

With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

JCO 2018

Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

NEJM 2018

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

NEJM 2018

Predictive performance of the quick Sequential Organ Failure Assessment score as a screening

tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia

Suppoet Care Cancer

2018

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

NEJM 2018

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Lancet 2018

日付

担当者

まとめ

Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids.

児玉

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

濵元

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

中村

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.

30343028

井上

（研）

日付

担当者

まとめ

Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

増谷

呉

Proactive Use of High-Flow Nasal Cannula With Critically Ill Subjects.

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.

 Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.

A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary

Aspergillosis Complicating Asthma

Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection

Management of severe sepsis in patients admitted to Asian intensive care units:

prospective cohort study

Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia

日付

担当者

まとめ

Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.